◆英語タイトル:Ahn-Gook Pharmaceutical Co Ltd (001540) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011927
◆発行会社(調査会社):
GlobalData
◆発行日:2017年12月13日
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:韓国
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
Ahn-Gook Pharmaceutical Co Ltd (Ahn-Gook Pharmaceutical) is a developer and supplier of medicines. The company provides health functional food, medical device, ethical drug, over the counter drugs, and others. Its products include acefenac tab, ahngook carvedilol tab, ahngook cefaclor cap, ahngook cilostazol tab, ahngook rebamipide tab, eletin sol, eletin tab, losastar tab, suprafen tab, tobicom-s soft cap. levotension tab. tobicomkid q-10 chewable tablet. Ahn-Gook Pharmaceutical develops products in various therapeutic areas such as respiratory, central nervous system, cancer, neurology, nephrology, orthopedic, gastroentirology and infectious diseases. The company markets its products in Ireland, South Korea, Germany, France, China, India, Japan and the US. Ahn-Gook Pharmaceutical is headquartered in Seoul, South Korea.
Ahn-Gook Pharmaceutical Co Ltd (001540) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ahn-Gook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ahn-Gook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ahn-Gook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ahn-Gook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ahn-Gook Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Ahn-Gook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ahn-Gook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Ahn-Gook Enters into Agreement with CorePharm 11
JW Pharmaceutical Enters into Co-Marketing Agreement with Ahn-Gook 12
EffRx Pharma Enters Into Distribution Agreement With Ahn-Gook Pharma For Binosto 13
Licensing Agreements 14
Ahn-Gook Pharma Enters into Licensing Agreement with Aprilbio 14
Gravity Bio Enters Into Licensing Agreement With Ahn-Gook Pharma For Synatura Drug 15
Ahn-Gook Pharma Enters Into Licensing Agreement With Hebang For Anycough 16
Ahn-Gook Pharm Enters Into Licensing Agreement With Grupo Uriach For Rhinitis Drug 17
Equity Offering 18
Ahn-Gook Pharma Completes Private Placement Of Common Stock For US$0.3 Million 18
Debt Offering 19
Ahn-Gook Pharma Completes Public Offering Of Convertible Bonds For US$0.6 Million 19
Ahn-Gook Pharmaceutical Co Ltd – Key Competitors 20
Ahn-Gook Pharmaceutical Co Ltd – Key Employees 21
Ahn-Gook Pharmaceutical Co Ltd – Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23
List of Tables
Ahn-Gook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Ahn-Gook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ahn-Gook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ahn-Gook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ahn-Gook Pharmaceutical Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Ahn-Gook Pharmaceutical Co Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Ahn-Gook Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ahn-Gook Enters into Agreement with CorePharm 11
JW Pharmaceutical Enters into Co-Marketing Agreement with Ahn-Gook 12
EffRx Pharma Enters Into Distribution Agreement With Ahn-Gook Pharma For Binosto 13
Ahn-Gook Pharma Enters into Licensing Agreement with Aprilbio 14
Gravity Bio Enters Into Licensing Agreement With Ahn-Gook Pharma For Synatura Drug 15
Ahn-Gook Pharma Enters Into Licensing Agreement With Hebang For Anycough 16
Ahn-Gook Pharm Enters Into Licensing Agreement With Grupo Uriach For Rhinitis Drug 17
Ahn-Gook Pharma Completes Private Placement Of Common Stock For US$0.3 Million 18
Ahn-Gook Pharma Completes Public Offering Of Convertible Bonds For US$0.6 Million 19
Ahn-Gook Pharmaceutical Co Ltd, Key Competitors 20
Ahn-Gook Pharmaceutical Co Ltd, Key Employees 21